Pfizer and Roche place $10bn bets on obesity and liver disease therapies as Trump tightens grip on drug pricing and manufacturing
The deals come against a backdrop of sweeping trade and pricing policies from Trump’s administration.
The deals come against a backdrop of sweeping trade and pricing policies from Trump’s administration.
